• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOMEDICS GROUP CANADA BLOOD PRESSURE MONITOR; SYSTEM, MEASUREMENT, BLOOD-PRESSURE, NON-INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOMEDICS GROUP CANADA BLOOD PRESSURE MONITOR; SYSTEM, MEASUREMENT, BLOOD-PRESSURE, NON-INVASIVE Back to Search Results
Model Number WGNBPA-950
Device Problem Low Readings (2460)
Patient Problem Headache (1880)
Event Description
This machine gives me low readings and therefore, i have not taken my blood pressure medication in weeks, and i have been having headaches and pressure in my eyesight.
 
Event Description
Additional information received from reporter on 02/09/2023 for mw5114567.My blood pressure has been registering very low numbers, and therefore causing me to not take my blood pressure medication in fear of my heart stopping.If i don't hear back from this company i will be seeking a lawyer's advice.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLOOD PRESSURE MONITOR
Type of Device
SYSTEM, MEASUREMENT, BLOOD-PRESSURE, NON-INVASIVE
Manufacturer (Section D)
HOMEDICS GROUP CANADA
MDR Report Key16272029
MDR Text Key308581493
Report NumberMW5114567
Device Sequence Number1
Product Code DXN
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial,Followup
Report Date 02/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Model NumberWGNBPA-950
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/30/2023
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/09/2023
Patient Sequence Number1
-
-